Why the study?
Does Angiotensin-(1-7) prevent systolic hypertension and kidney injury in Type 1 diabetic Akita mice?
Population
Male Type 1 diabetic Akita mice starting at 14 weeks of age
Comparison
Angiotensin- 500 μg/kg/day subcutaneously, with… vs Age-matched wild-type (WT) mice
Design
Preclinical
Follow-up
6 weeks (from 14 to 20 weeks of age)
Authors
Loading...
Supports MasR agonism for diabetic nephropathy in mice; leaves open human translation.
Does Angiotensin-(1-7) prevent systolic hypertension and kidney injury in Type 1 diabetic Akita mice?
Angiotensin-(1-7) prevents systolic hypertension and diabetic nephropathy in a Type 1 diabetes mouse model via Mas receptor activation and reduction of oxidative stress.
Shi et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: